Recherche
-
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
(Frontiers in Endocrinology. vol. 14, pp. 1254221, 2023-09-25)Article de revueLibre accès -
Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 11, pp. 624562, 2021-03-24)Article de revueLibre accès -
Emergency room admissions induced by drug-drug interactions in the elderly: a cross-sectional study
(Clinical and Translational Science, 2022-03-04)Article de revueLibre accès -
Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
(Frontiers in Pharmacology. vol. 12, pp. 668765, 2021-05-28)Article de revueLibre accès -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue